• Home
  • Store
    • Total Access Subscriptions
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • Toolkit
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » Authors » Talia Puzantian, PharmD, BCPP

Articles by Talia Puzantian, PharmD, BCPP

Fact Sheet

Management of Agitation in Children and Adolescents in Hospital Settings

January 1, 2025
Joshua Feder, MD, Elizabeth Tien, MD, and Talia Puzantian, PharmD, BCPP

Dr. Feder, Dr. Tien, and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

When managing agitation in children and adolescents in hospital settings, you’re not just focusing on their immediate safety and that of those around them; you’re also trying to minimize the trauma that can occur in such high-stress environments. In this guide, we’ll walk through the core principles for handling these sensitive situations.


Read More
Patient Sheet

Understanding Metabolic Syndrome: A Fact Sheet for Patients

January 1, 2025
Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD

Metabolic syndrome is a cluster of conditions that increase the risk of cardiovascular diseases, diabetes, and stroke.


Read More
Fact Sheet

Vagus Nerve Stimulation (VNS) Fact Sheet

January 1, 2025
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

The efficacy of VNS remains too controversial to recommend its use in all but the most desperate clinical situations.


Read More
Fact Sheet

Transcranial Magnetic Stimulation (TMS) Fact Sheet

January 1, 2025
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

TMS is a reasonable option for patients who have failed several antidepressant trials and who are willing to commit to daily clinic visits for up to six weeks.


Read More
Fact Sheet

L-Tryptophan Fact Sheet [G]

January 1, 2025
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

L-tryptophan is an amino acid precursor to serotonin, but evidence for its use in depression is extremely limited.


Read More
Algorithm

ADHD Treatment Algorithm

November 19, 2024
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

ADHD Treatment Algorithm




Read More
Clinical Guidance

Bipolar Disorder Treatment Algorithm

November 19, 2024
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Bipolar mania and depression treatment algorithms




Read More
News of Note

News of Note: Donanemab Gains FDA Approval for Early Alzheimer’s Treatment

October 1, 2024
Stephanie Collier, MD and Talia Puzantian, PharmD, BCPP
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Stephanie Collier, MD and Talia Puzantian, PharmD. Dr. Collier and Dr. Puzantian have no financial relationships with companies related to this material.

The FDA recently approved donanemab for early Alzheimer’s, offering new hope by slowing cognitive decline.


Read More
Clinical Update

Considerations in Prescribing Lithium in Older Adults

October 1, 2024
Shireen Wissa, PharmD and Talia Puzantian, PharmD, BCPP
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Shireen Wissa, PharmD Candidate 2025. Keck Graduate Institute School of Pharmacy, Claremont, CA.

Talia Puzantian, PharmD, BCPP. Keck Graduate Institute School of Pharmacy, ­Claremont, CA.

Ms. Wissa and Dr. Puzantian have no financial relationships with companies related to this material.

Smart dosing and vigilant monitoring can turn the often-feared lithium into a safe, effective solution for older adults.


Read More
Fact Sheet

Antipsychotic Comparison: Quick Reference

September 30, 2024
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Listing is alphabetical by brand name. 


Read More
Previous 1 2 … 27 28 29 30 31 32 33 34 35 … 43 44 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • MFB8e_SpiralCover.png

    Medication Fact Book for Psychiatric Practice, Eighth Edition (2026)

    Updated 2026 prescriber's guide.
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • supportive psychotherapy Dalle 11082023.jpg
    Psychology and Social Work

    Treating BPD Series, Episode 2: Transference-Focused Psychotherapy—From Splitting to Coherence with Frank Yeomans, MD, PhD

    In this episode, Dr. Frank Yeomans offers a deep dive into the theory and clinical practice of TFP as a treatment for Borderline Personality Disorder.

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2026 Carlat Publishing, LLC and Affiliates, All Rights Reserved.